申请人:MERCK SHARP & DOHME CORP.
公开号:US20140296203A1
公开(公告)日:2014-10-02
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1).
本发明公开了式(1)的ERK抑制剂及其药学上可接受的盐。同时公开了使用式(1)的化合物治疗癌症的方法。